SG11201908629WA - Anti-inflammatory agent - Google Patents

Anti-inflammatory agent

Info

Publication number
SG11201908629WA
SG11201908629WA SG11201908629WA SG11201908629WA SG 11201908629W A SG11201908629W A SG 11201908629WA SG 11201908629W A SG11201908629W A SG 11201908629WA SG 11201908629W A SG11201908629W A SG 11201908629WA
Authority
SG
Singapore
Prior art keywords
inflammatory agent
composition
pop
present
olanexidine
Prior art date
Application number
Inventor
Takuya Nii
Akifumi Hagi
Yoshie Tsubotani
Original Assignee
Otsuka Pharma Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Factory Inc filed Critical Otsuka Pharma Factory Inc
Publication of SG11201908629WA publication Critical patent/SG11201908629WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Abstract

ANTI-INFLAMMATORY AGENT An object of the present invention is to provide a composition that can be used as a novel anti-inflammatory agent. An inflammation such as stomatitis, oral mucositis, gingivitis, or pneumonia can be ameliorated and/or prevented by using a composition comprising olanexidine or a pharmacologically acceptable salt thereof. The composition of the present invention preferably further comprises a poloxamer which is a block copolymer consisting of a chain of polyoxypropylene (POP) and two chains of polyoxyethylene (POE) flanking the POP. [Fig. 18]
SG11201908629W 2017-04-19 2018-04-10 Anti-inflammatory agent SG11201908629WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017082793 2017-04-19
PCT/JP2018/014999 WO2018193904A1 (en) 2017-04-19 2018-04-10 Anti-inflammatory agent

Publications (1)

Publication Number Publication Date
SG11201908629WA true SG11201908629WA (en) 2019-10-30

Family

ID=63855845

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201908629W SG11201908629WA (en) 2017-04-19 2018-04-10 Anti-inflammatory agent

Country Status (13)

Country Link
US (1) US11229615B2 (en)
EP (1) EP3628314B1 (en)
JP (1) JP6802365B2 (en)
KR (1) KR102253831B1 (en)
CN (1) CN110494132A (en)
AU (1) AU2018256060B2 (en)
CA (1) CA3058592C (en)
ES (1) ES2956040T3 (en)
PH (1) PH12019550207A1 (en)
RU (1) RU2738845C1 (en)
SG (1) SG11201908629WA (en)
TW (1) TWI675658B (en)
WO (1) WO2018193904A1 (en)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2064664C (en) 1991-04-05 2000-01-11 Hiroshi Ishikawa Biguanide derivatives, manufacturing method thereof, and disinfectants containing the derivatives
US20020013331A1 (en) 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
US6685917B2 (en) * 2000-11-22 2004-02-03 Rxkinetix, Inc. Treatment of mucositis
TW200509893A (en) * 2003-05-28 2005-03-16 Otsuka Pharma Co Ltd A composition for sterilizing and/ or disinfecting
JP4580153B2 (en) * 2003-06-30 2010-11-10 大塚製薬株式会社 Disinfecting and / or disinfecting composition
BRPI0410851B8 (en) * 2003-05-28 2023-04-25 Otsuka Pharma Co Ltd OLANEXIDINE AQUEOUS SOLUTION, METHOD OF PREPARATION OF THE AQUEOUS SOLUTION, DISINFECTANT, ITS USE AND METHOD OF DISINFECTION OR STERILIZATION OF AN OBJECT
JP4526300B2 (en) * 2003-05-28 2010-08-18 大塚製薬株式会社 Oranexidine aqueous solution, its preparation method and disinfectant
JP4541661B2 (en) * 2003-05-28 2010-09-08 大塚製薬株式会社 Disinfecting and / or disinfecting composition
JP2005343964A (en) * 2004-06-01 2005-12-15 Otsuka Pharmaceut Factory Inc Aqueous solution containing polyalkylene glycol and method for preparing the same
KR20070088636A (en) 2004-11-17 2007-08-29 오츠카 아메리카 파마슈티컬, 인코포레이티드 Fluid application device and method
WO2006122162A2 (en) * 2005-05-10 2006-11-16 The University Of Chicago Use of peptides derived from the growth factor amp-18 for the treatment of mucositis
EP1986790B1 (en) 2006-02-14 2021-05-19 Allegiance Corporation Liquid applicator and method for reducing the concentration of by-products from antiseptic
TWI556845B (en) * 2008-12-30 2016-11-11 大塚美國製藥股份有限公司 Fluid application device and method
US9801916B2 (en) * 2013-02-07 2017-10-31 Tomás Bernardo Galvan Gonzalez Oral antiseptic composition useful for treating oral mucositis
US20150231095A1 (en) * 2013-04-18 2015-08-20 Steven A. Melman Antimicrobial compositions and uses therefore
NO342617B1 (en) 2014-06-18 2018-06-18 Meda Otc Ab Oral formulation comprising an antibacterial agent to prevent and / or treat halitosis, bad breath, dry mouth or sore throat
JP6602639B2 (en) * 2015-10-21 2019-11-06 株式会社大塚製薬工場 Composition for improving or preventing oral mucositis by treating cancer

Also Published As

Publication number Publication date
AU2018256060B2 (en) 2020-08-06
KR102253831B1 (en) 2021-05-20
ES2956040T3 (en) 2023-12-12
AU2018256060A1 (en) 2019-10-17
TWI675658B (en) 2019-11-01
JPWO2018193904A1 (en) 2020-01-09
CA3058592A1 (en) 2018-10-25
US11229615B2 (en) 2022-01-25
RU2738845C1 (en) 2020-12-17
CN110494132A (en) 2019-11-22
CA3058592C (en) 2021-11-09
PH12019550207A1 (en) 2020-09-21
US20210121417A1 (en) 2021-04-29
EP3628314A4 (en) 2020-10-28
TW201841631A (en) 2018-12-01
EP3628314B1 (en) 2023-07-26
WO2018193904A1 (en) 2018-10-25
JP6802365B2 (en) 2020-12-16
EP3628314A1 (en) 2020-04-01
KR20190123780A (en) 2019-11-01

Similar Documents

Publication Publication Date Title
CR20220070A (en) Parp1 inhibitors
CA3148745A1 (en) Kras g12d inhibitors
MX2019007187A (en) Oral care compositions.
MX2021000093A (en) Tlr7/8 antagonists and uses thereof.
EP4248968A3 (en) Tlr7/8 antagonists and uses thereof
CY1126067T1 (en) FUSIONED PYROLINES THAT ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30) INHIBITORS
MX2018003975A (en) Combination of glycosaminoglycans and an antacid agent and compositions thereof.
PH12015501783A1 (en) Pharmaceutical compositions for the treatment of helicobacter pylori
CA3156259A1 (en) Methods of use of oral care compositions comprising hops
MX2022001690A (en) Deuterated compounds for use in the treatment of cancer.
EA202192867A1 (en) EXTENDED RELEASE FORMULATIONS
PH12019501424A1 (en) Carboxylic acid aromatic amides as antagonists of bradykinin b1 receptor
ZA202006377B (en) Boronic acid derivatives and therapeutic uses thereof
WO2021046315A3 (en) Inhibitors of encephalitic alphaviruses
MX2019007361A (en) Oral care compositions.
AR097678A1 (en) COMPOSITION FOR ORAL CARE THAT INCLUDES A DILUTED GEL OF SODIUM AND CALCIUM ALGINATE
SG11201908629WA (en) Anti-inflammatory agent
NZ757526A (en) Naphthoquinones, their derivatives and uses thereof in methods for the treatment of mitochondrial dysfunction
PH12020500204A1 (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic disease
CR20200353A (en) Thixotropic antimicrobial composition
MX2021001145A (en) Immediate release formulation of a triple combination of active pharmaceutical ingredients useful in the treatment of polycystic ovary syndrome.
UA117200C2 (en) Oral topical aqueous pharmaceutical compositions of flurbiprofen and dexpanthenol
PH12017502039A1 (en) Oral care device
MX2019005495A (en) Oral care composition.
ZA202101942B (en) Oral care compositions comprising n-alkyl-n-acylglucamines